ASPIQT7ASP Isotopes Inc. Common Stock·NASDAQ
1.94-3.96%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E—EPS (ttm)-1.32Insider Own21.40%Shs Outstand153.31MPerf Week-3.96%
Market Cap297.42MForward P/E—EPS next Y-0.32Insider Trans-2.57%Shs Float133.05MPerf Month-33.33%
Enterprise Value312.42MPEG—EPS next Q-0.15Short Float21.83%Perf Quarter-54.78%
Income-133.00MP/S9.59EPS this Y—Short Ratio7.14Perf Half Y-62.40%
Sales31.00MP/B1.08EPS next Y—ROA-23.08%Short Interest29.05MPerf YTD-63.74%
Book/sh1.79P/C1.17EPS next 5Y—ROE-63.49%52W High10.76 -81.97%Perf Year-81.97%
Cash/sh1.66P/FCF—EPS past 3/5Y—ROIC-17.29%52W Low1.89 2.65%Perf 3Y84.76%
Dividend Est.—EV/EBITDA—Sales past 3/5Y—Gross Margin18.32%Volatility7.43% 7.90%Perf 5Y—
Dividend TTM—EV/Sales10.08EPS Y/Y TTM—Oper. Margin-312.31%ATR (14)0.20Perf 10Y—
Dividend Ex-Date—Quick Ratio3.85Sales Y/Y TTM675.00%Profit Margin-428.00%RSI (14)32.33Recom2.00
Dividend Gr. 3/5Y—Current Ratio3.87EPS Q/Q72.82%SMA20-13.45%Beta3.86Target Price9.50
Payout0.00%Debt/Eq0.98Sales Q/Q400.00%SMA50-33.94%Rel Volume0.76Prev Close2.02
Employees271LT Debt/Eq0.78EarningsNov 12SMA200-59.81%Avg Volume4.08MPrice1.94
IPO DateNov 10, 2022Option/ShortNo / YesEPS/Sales Surpr.-64.71% -9.72%Net Debt/EBITDA—Volume3,088,045Change-3.96%
Analyst Ratings
DateActionAnalystRatingTarget
Dec-04-25InitiatedCantor FitzgeraldOverweight$13
Oct-27-25ReiteratedLoop Capital Markets$15
Oct-04-24InitiatedCanaccordBuy$4.50
Apr-17-24ReiteratedHC Wainwright & Co.Buy$5.50
Latest News· Times ET
Oct-28-26
Oct-27-26
Oct-26-26
Oct-15-26
Oct-02-26
Sep-29-26
Sep-28-26
Sep-09-26
Sep-08-26
Sep-01-26
Aug-21-26
Aug-20-26
Company

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2019
12/31/2019
Total Revenue312440———
Cost of Goods Sold Incl. D&A262030———
Gross Profit5320———
Selling, General and Administrative Excl. Other80482515———
Research and Development221231———
Other Operating Expense0100———
Operating Income-96-57-26-16———
Interest Expense4100———
Unusual Expense
———————
Non-Operating Income (Expense)-37-102-60———
Net Income Before Taxes-137-160-32-16———
Income Taxes
0000———
Consolidated Net Income-133-175-32-16———
Net Income From Continuing Operations-137-160-32-16———
Net Income-133-175-32-16———
EPS (Recurring)-1.32-2.11-0.63-0.49———
EPS (Basic, Before Extraordinaries)-1.32-2.11-0.63-0.49———
EPS (Diluted)-1.32-2.11-0.63-0.49———
EBITDA-129-157-32-16———
Other After Tax Adjustments
———————
Stock Option Compensation Expense
———————
Price To Earnings Ratio
———————
Price To Sales Ratio7.7018.5063.42————
Gross Margin16.1312.5050.00————
Operating Margin-309.68-237.50-650.00————
Net Margin-429.03-729.17-800.00————
Shares Outstanding123835633———
Market Capitalization23944425459———
Operating Lease Expense
———————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$15.87$11.93$8.00$4.06$0.12● Close Price0.00M0.87M1.74M2.61M3.48MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Kiessling HeatherChief Financial OfficerOct 16 '26Sale2.1921,83047,8081,504,422Oct 21
Ainscow RobertCOOOct 14 '26Sale2.1122,50047,5652,225,941Oct 16
Ryan Robert John AndrewDirectorSep 30 '26Buy2.6815,00040,200675,222Oct 01
Ryan Robert John AndrewDirectorSep 28 '26Buy2.708,00021,600660,222Sep 30
Ainscow RobertCOOSep 08 '26Sale4.298,43836,2162,248,441Sep 10
Mann Paul ElliotChairman and CEOSep 04 '26Sale4.1083,759343,4129,328,570Sep 04
Mann Paul ElliotChairman and CEOSep 03 '26Sale3.9283,758328,3319,412,329Sep 04
Mann Paul ElliotChairman and CEOSep 02 '26Sale3.9183,758327,4949,496,087Sep 04
Ainscow RobertCOOSep 02 '26Sale3.9025,00097,6252,256,879Sep 04
Ainscow Donald GeorgeEVP, Gen Counsel, SecretarySep 02 '26Sale3.8923,67892,107776,322Sep 04
Kiessling HeatherChief Financial OfficerJul 01 '26Sale6.2823,124145,2191,526,252Jul 02
Ainscow Donald GeorgeEVP, Gen Counsel, SecretaryJun 30 '26Sale6.14100,000614,000800,000Jul 02
Wider ToddDirectorJun 30 '26Sale6.1250,000306,000672,247Jul 01
Gorley MichaelDirectorJun 30 '26Sale6.2730,000188,10087,908Jul 01
Wider ToddDirectorJun 29 '26Sale6.2550,000312,500722,247Jul 01
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.